Promedior Adds Howard J. Weisman to Board of Directors
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, announced today that Howard J. Weisman has been appointed to the company’s Board of Directors. Mr. Weisman is an accomplished entrepreneur and pharmaceutical company executive who brings a diversity of experience leading the growth of a number of companies and businesses in the life sciences industry.
Help employers find you! Check out all the jobs and post your resume.
Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, announced today that Howard J. Weisman has been appointed to the company’s Board of Directors. Mr. Weisman is an accomplished entrepreneur and pharmaceutical company executive who brings a diversity of experience leading the growth of a number of companies and businesses in the life sciences industry.
Help employers find you! Check out all the jobs and post your resume.